Chronic Wound Care

  • Pressure Ulcers
  • Vascular Ulcers
  • Neuropathic Ulcers (e.g., Diabetic Foot Ulcers)
  • Other Chronic and Acute Wounds
  • Blisters

It is estimated that 1 to 2% of the population will experience a chronic wound during their lifetime in developed countries.

Existing wound care products have limitations such as slow hemostasis, significant pain, delayed healing, risk of infections, require multiple procedures, discoloration, scarring, and wound complications.

All of these challenges can be effectively addressed with BloodSTOP® iX.

Why use BloodSTOP® iX for chronic wound treatment?

BloodSTOP iX addresses the issue of long healing time in wounds such as diabetic foot ulcers, leading to higher risk of amputations. The median time in healing diabetic foot ulcers without surgery is usually 84 days as compared to only 21 days for skin to regenerate after application of BloodSTOP iX as shown in a histology report (Figure 3).

Figure 1.  After debridement
Figure 2.  Hemostasis with BloodSTOP iX gel
Figure 3.  Healing with BloodSTOP iX

BloodSTOP iX functions in:

  • Providing rapid hemostasis for acute and chronic wounds
  • Facilitating fast healing in ulcer wounds after debridement
  • Sealing the wound as it turns into a gel upon contact with blood and exudate, protecting wounds, and preventing contamination
  • Facilitating proliferation of new skin growth within 7 days on donor sites and skin grafts in full-thickness burns (American Burn Association 2019 Best-in-Category Award Winner)
  • Preventing production of excessive exudates

More information on producer site here.

Back to product page